Please forward this error screen to 10. Foster innovation, drive significant the career cluster that contains securities and investments is benefit and generate superior returns by creating and investing in innovative life science companies.
Our Fund Investment Focus: Our primary focus is on the development of novel therapeutics and platforms. Pacific with approximately USD 800 million under management in committed capital and more than 40 portfolio companies. We continue our strategy of making larger focused investments and anticipate total investments up to USD 30 million per company over its life. NVF is stage agnostic and engages in seed investments as well as later-stage investments. We typically lead or co-lead an investment and play an active role on company boards.
Pipeline Overview of Biotechnology Portfolio The Novartis Venture Fund has investments across various therapeutic areas. We seek companies that are truly innovative, have the potential to offer significant patient benefit, have excellent management and are capital-efficient. In total, our current portfolio companies have 21 clinical programs in Phase 1 or Phase 2. Seeking Healthcare Innovation Physicians use a combination of technologies to produce the best clinical outcome. The challenges and opportunities in healthcare are multi-factorial. Our fund looks broadly to invest in all types of healthcare innovation that will to serve clinical need. The Novartis Venture Fund has invested in medical technologies and diagnostics since its inception in 1996.
Our device investments are led by Steven Weinstein in our Cambridge office. Our Focus Our definition of medical technologies is broad. The NVF seeks opportunities that can change the practice of medicine, produce meaningful patient benefit, or reduce costs of medical care. We look for underserved indications, or where a company’s technology enables a new treatment paradigm. Our Portfolio Advanced Animal Diagnostics, Inc.
On-farm diagnostics platform to detect disease states and optimize overall health status of production animals. Molecular diagnostic system for the ultra-rapid diagnosis of a broad range of infectious diseases. Implantable neurostimulation device for severe headaches such as cluster headaches and migraines. Genome mapping platform using nanochannel technology to visualize whole genomes of any organism, including humans.